Navigation Links
IntegriChain® Announces Release of DNA 2.0
Date:6/12/2012

PRINCETON, N.J., June 12, 2012 /PRNewswire/ -- IntegriChain, Inc., the developer of the DNA channel data and application cloud, announced today the release of DNA 2.0.  As the latest version of the company's flagship product, DNA 2.0 provides customers a next-generation suite of interactive analytics, point-of-sale reporting and real-time demand sensing.

(Logo: http://photos.prnewswire.com/prnh/20111130/NY15137LOGO )

Channel visibility is a major focus of the DNA 2.0 release, enabling users to access factory sales, wholesale inventory, retail inventory, retail stocking and point-of-sale purchases in a single integrated reporting and analytics tool.  Another enhancement provides users with real-time email notifications and exception dashboards for a growing range of order, distributor, and downstream channel metrics.

DNA 2.0 also includes major enhancements to the DNA cloud's infrastructure, greatly boosting speed and flexibility.  With the implementation of InfoBright® (a columnar database technology), and Dell™ Everest servers (which contain Intel®'s next-generation of processors), DNA 2.0 users can request, pivot and report on millions of channel data records in seconds.

Kevin Leininger, CEO of IntegriChain, stated, "Pre-canned reports are simply too limiting.  Healthcare manufacturers are more and more analytical.  They need to access their channel data in a way that is flexible and scales across large portfolios of SKUs and hundreds of thousands of points of sale.  DNA users can pull years of detailed inventory and distribution sales data in seconds, and spin and drill into this data without advanced technical knowledge."

DNA 2.0 also includes the industry's most robust process for detecting and investigating accuracy and completeness issues in EDI 852 and EDI 867 data — including real-time monitoring of inventory and sales data validity, file timeliness, and file completeness.

"DNA 2.0 is the first system to fully realize our customers' vision for complete, timely visibility to the forward channel," added Josh Halpern, IntegriChain VP of Marketing.  "By raising the industry standard for data quality, system performance, and ease of use, DNA is helping more and more manufacturers to put channel data at the heart of their customer and operational strategies."

About IntegriChain
IntegriChain, Inc. is the developer of DNA, the leading enterprise cloud for real-time channel data and analytic applications.  DNA data and apps provide manufacturers 100% visibility to their forward channels with unprecedented ease of use, speed and transparency.  DNA's end-to-end platform and self-service analytics eliminate the IT bottleneck between business users and their data, thereby accelerating enterprise decision-making.  Located in Princeton, New Jersey, IntegriChain has been recognized on both the Inc 500 and the Red Herring 100 lists of America's Fastest Growing Companies, and is nineteenth on the Forbes 2011 list of America's Most Promising Companies. For more information, please visit www.integrichain.com

All names referred to are trademarks or registered trademarks of their respective owners.

Contact: Ally Hanlon
IntegriChain, Inc.
Phone: 609.986.2004
Fax: 609.806.5006
info@integrichain.com


'/>"/>
SOURCE IntegriChain, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. American HealthTech Announces Streamlined Connectivity With LTC Trend Tracker
2. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
3. Law Office of Brodsky & Smith, LLC Announces Investigation of SRI Surgical Express, Inc.
4. Forum Extended Care Services Announces Plans to Move to Larger, State-Of-the-art Facility
5. Nonin Medical, Inc. Announces U.S. Market Release of EQUANOX™ Advance Model 8004CB Series Sensor for Neonatal, Pediatric Patients
6. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
7. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
8. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
9. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
10. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
11. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Planet Fitness, ... the U.S., announced today its plans to open a flagship location in Covington, LA ... the former Rooms To Go store next to Office Depot in the Holiday Square ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... $3,296 in property taxes a year. In some states—like New York, New Jersey, ... By contrast, many overseas retirement havens have extremely low property-tax rates, which contributes ...
Breaking Medicine News(10 mins):